
Credit card-sized TB test finds hidden infections in patients with HIV; this common mouth bacteria could predict survival in head and neck cancer; many older women may unknowingly have brain tumors – Morning Medical Update
Key Takeaways
- ASTRA, a new TB test, enhances detection in HIV patients with 87% specificity, outperforming traditional IGRA tests. It is electricity-free and delivers results in four hours.
- Fusobacterium nucleatum presence in head and neck cancer tumors correlates with improved survival, suggesting its role as a prognostic biomarker for personalized treatment strategies.
The top news stories in medicine today.
Tulane University researchers have developed a handheld, electricity-free tuberculosis test that dramatically improves detection in people with HIV — who often go undiagnosed with current tools. Inspired by the chemical defense of bombardier beetles, the device — called ASTRA — uses a drop of blood and delivers results in four hours. In trials, ASTRA outperformed traditional IGRA tests in HIV patients, detecting TB with 87% specificity versus 60%. Published in
Brazilian researchers have found that the oral bacterium Fusobacterium nucleatum was present in nearly 60% of head and neck cancer tumors—and its presence may signal better outcomes. Patients with the bacteria had an average survival of 60 months, compared to 36 months for those without. The study, published in
A new Swedish study finds that 2.7% of 70-year-old women may have undetected meningiomas — typically benign tumors that grow on the brain’s outer membranes. Researchers at the University of Gothenburg, using data from the H70 population study, stress that while most cases require only monitoring, incidental findings during MRIs could lead to unnecessary surgeries. The findings, published in
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.
















